Site Editor

Rebecca Olin, MD, MS


Alexander E. Perl, MD, on What the Updated AML Guidelines Mean for Clinical Practice

Posted: Wednesday, April 7, 2021

Alexander E. Perl, MD, of the Abramson Cancer Center at the University of Pennsylvania, discusses changes to the NCCN Clinical Practice Guidelines in Oncology® for managing acute myeloid leukemia and how he approaches the selection of therapies, as well as financial and treatment-related toxicities.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.